These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28472340)

  • 1. MiSTIC, an integrated platform for the analysis of heterogeneity in large tumour transcriptome datasets.
    Lemieux S; Sargeant T; Laperrière D; Ismail H; Boucher G; Rozendaal M; Lavallée VP; Ashton-Beaucage D; Wilhelm B; Hébert J; Hilton DJ; Mader S; Sauvageau G
    Nucleic Acids Res; 2017 Jul; 45(13):e122. PubMed ID: 28472340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectral clustering using Nyström approximation for the accurate identification of cancer molecular subtypes.
    Shi M; Xu G
    Sci Rep; 2017 Jul; 7(1):4896. PubMed ID: 28687729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
    Culhane AC; Perrière G; Higgins DG
    BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based sub-network signatures unveil the potential for acute myeloid leukemia therapy.
    Shi M; Wu M; Pan P; Zhao R
    Mol Biosyst; 2014 Dec; 10(12):3290-7. PubMed ID: 25313005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signatures in breast cancer.
    Lal S; McCart Reed AE; de Luca XM; Simpson PT
    Methods; 2017 Dec; 131():135-146. PubMed ID: 28669865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
    Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
    Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
    Liu R; Lv QL; Yu J; Hu L; Zhang LH; Cheng Y; Zhou HH
    Breast Cancer Res Treat; 2015 Jun; 151(3):607-18. PubMed ID: 25981901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Master regulators used as breast cancer metastasis classifier.
    Lim WK; Lyashenko E; Califano A
    Pac Symp Biocomput; 2009; ():504-15. PubMed ID: 19209726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
    Tishchenko I; Milioli HH; Riveros C; Moscato P
    PLoS One; 2016; 11(6):e0158259. PubMed ID: 27341628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic hallmarks in AML.
    Clarke MA; Fisher J
    Nat Biomed Eng; 2019 Nov; 3(11):847-849. PubMed ID: 31705121
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.
    Abu-Jamous B; Buffa FM; Harris AL; Nandi AK
    Mol Cancer; 2017 Jun; 16(1):105. PubMed ID: 28619028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BubbleGUM: automatic extraction of phenotype molecular signatures and comprehensive visualization of multiple Gene Set Enrichment Analyses.
    Spinelli L; Carpentier S; Montañana Sanchis F; Dalod M; Vu Manh TP
    BMC Genomics; 2015 Oct; 16():814. PubMed ID: 26481321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.
    Huang Z; Duan H; Li H
    Biomed Res Int; 2015; 2015():878546. PubMed ID: 26576432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of 2,000 breast cancer metabolic landscapes reveals a poor prognosis group with active serotonin production.
    Leoncikas V; Wu H; Ward LT; Kierzek AM; Plant NJ
    Sci Rep; 2016 Jan; 6():19771. PubMed ID: 26813959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VisANT: an online visualization and analysis tool for biological interaction data.
    Hu Z; Mellor J; Wu J; DeLisi C
    BMC Bioinformatics; 2004 Feb; 5():17. PubMed ID: 15028117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.
    Fu L; Shi J; Hu K; Wang J; Wang W; Ke X
    Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of alternative transcripts in human breast cancer.
    Wen J; Toomer KH; Chen Z; Cai X
    Breast Cancer Res Treat; 2015 Jun; 151(2):295-307. PubMed ID: 25913416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence.
    Wang YK; Print CG; Crampin EJ
    BMC Genomics; 2013 Feb; 14():102. PubMed ID: 23405961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.